Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various...
155 insider purchases on record · latest filing 2023-06-28.
Insiders have also filed 282 sale transactions at RPRX.